Theranostics Therapy

Cancer Theranostics uses one of the most potent cancer therapies, radiation, taking it to the cellular level. Doctors can find and treat cancer with precision using a PET scan to locate and mark cancer cells anywhere in the body. They use an infusion of specialized medicine to deliver radiation to destroy the cells. Thanks to the targeted precision, we can help to protect healthy tissue near the cancer cells, which reduces your risk for side effects. The Northeast Louisiana Cancer Institute is now pleased to offer PLUVICTO™ as a part of our Cancer Theranostic program.

About PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan)

PLUVICTO is the first and only approved prescription treatment used to treat adults with prostate-specific membrane antigen¬–¬positive metastatic castration-resistant prostate cancer (PSMA-positive mCRPC) already treated with:

• hormone therapy and are considered appropriate to delay chemotherapy or
• hormone therapy and chemotherapy

PLUVICTO™ is administered as solution for infusion given over 30 minutes every 6 weeks for up to 6 treatments, or until disease progression, or unacceptable toxicity. The PSMA-targeted Radioligand Therapy (RLT) delivers DNA-breaking radiation directly to PSMA+ bone, nodal, and visceral metastases.